Society Letters Society Letters

Endocrine Society Provides Guidance to FDA on Developing Drugs for Cushing's Syndrome

November 06, 2023

Dear members of the FDA Committee,

"We would like to take this opportunity to comment on the draft guidelines on Cushing’s syndrome titled above. We represent the leadership of the international Pituitary Society and the Endocrine Society and are highly experienced with pharmaceutical trials involving Cushing’s syndrome."

arrow Read the Full Letter

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.